Trading on split-adjusted basis will begin at market open on May 29, 2026. This adjustment is expected to help Silexion ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Who doesn't love a stock split? All of a sudden, with no effort required on your part, you own many more shares of a stock. It certainly sounds great -- and lucrative -- but stock splits are actually ...

Republic Power Group Limited (NASDAQ: RPGL), today announced that it will effect a reverse share split of its Class A ordinary shares, par value $0.0125 per share (the 'Class A Ordinary Shares”) and ...

It won't be surprising to see Sandisk management opting for a forward stock split following the stock's impressive surge over the past year.

Shares of the Funds will begin trading on the NASDAQ on a split-adjusted basis on July 09, 2025 (the “Ex-Date”). On the Ex-Date, the opening market value of the Fund’s issued and outstanding shares, ...

Electra Battery Materials (ELBM) announces that effective at the close of business on December 31, 2024, the Company will effect a reverse share split of its outstanding common share capital on the ...

As of yesterday’s market close, Netflix is the only Big Tech company whose stock is trading at four figures, but that will soon change. The TV streaming giant, whose shares closed at $1,089 on ...

Companies conduct stock splits to allow investors to purchase their shares at a more affordable price. Tech giant and Magnificent 7 leader Nvidia is no exception, having split its stock several times ...

When a company announces a stock split, its share price suddenly drops, and investors often rush in, thinking the stock has ...

Ostin Technology (OST) Group announced an update to the effective date of its previously approved reverse share split of the Company’s Class A ordinary shares, with the split ratio set at 1-for-10.

Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies ...